M C27 (Clopidogrel bisulfate 75 mg (base))

Pill imprint M C27 has been identified as Clopidogrel bisulfate 75 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; transient ischemic attack; heart attack; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 75 mg (base) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M C27

Clopidogrel bisulfate 75 mg (base) M C27
Clopidogrel bisulfate
Imprint:
M
C27
Strength:
75 mg (base)
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals, Inc.
National Drug Code (NDC):
00378-3627
Inactive Ingredients:
lactose anhydrous
silicon dioxide
croscarmellose sodium
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
sodium lauryl sulfate
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)